Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Non Operating Income (2020 - 2022)

Historic Non Operating Income for Terns Pharmaceuticals (TERN) over the last 3 years, with Q4 2022 value amounting to $1.3 million.

  • Terns Pharmaceuticals' Non Operating Income rose 193692.31% to $1.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was $2.0 million, marking a year-over-year increase of 92613.07%. This contributed to the annual value of $13.3 million for FY2024, which is 548.98% up from last year.
  • Terns Pharmaceuticals' Non Operating Income amounted to $1.3 million in Q4 2022, which was up 193692.31% from $485000.0 recorded in Q3 2022.
  • Terns Pharmaceuticals' 5-year Non Operating Income high stood at $1.3 million for Q4 2022, and its period low was -$2.8 million during Q3 2020.
  • For the 3-year period, Terns Pharmaceuticals' Non Operating Income averaged around -$41000.0, with its median value being $83500.0 (2021).
  • In the last 5 years, Terns Pharmaceuticals' Non Operating Income tumbled by 10599.08% in 2021 and then soared by 193692.31% in 2022.
  • Terns Pharmaceuticals' Non Operating Income (Quarter) stood at -$450000.0 in 2020, then skyrocketed by 114.44% to $65000.0 in 2021, then skyrocketed by 1936.92% to $1.3 million in 2022.
  • Its Non Operating Income stands at $1.3 million for Q4 2022, versus $485000.0 for Q3 2022 and $160000.0 for Q2 2022.